Interleukin-6 induces increased motility, cell-cell and cell-substrate dyshesion and epithelial-to-mesenchymal transformation in breast cancer cells

Oncogene

Volumn 29, Issue 17, 2010, Pages 2599-2600

  Sehgal, P B ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

BREAST CANCER; BREAST CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; EPITHELIUM CELL; HUMAN; LETTER; MESENCHYME CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; EPITHELIUM; FEMALE; HUMANS; INTERLEUKIN-6; MESODERM;

EID: 77951878181     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.4     Document Type: Letter

References (19)

1. Bromberg J, Wang TC. (2009). Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15: 17-80.
2. 2. Proc Natl Acad Sci USA 85: 8037-8041.
3. Chen L, Shulman LM, Revel M. (1991). IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells. J Biol Regul Homeostat Agents 5: 125-136.
4. Chiu JJ, Sgagias MK, Cowan KH. (1996). Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 2: 215-221.
5. Choppin PW. (2007). A Biographical Memoir of Igor Tamm (1922-1995). National Academy of Sciences USA: Washington, DC, pp 1-17.
6. Krueger J, Ray A, Tamm I, Sehgal PB. (1991). Expression and function of interleukin-6 in epithelial cells. J Cell Biochem 45: 327-334.
7. Margulies L, Sehgal PB. (1993). Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBPb (NF-IL6) activity by p53 species. J Biol Chem 268: 15096-15100.
8. Sehgal PB. (1990). Interleukin 6 in infection and cancer. Proc Soc Exp Biol Med 195: 183-191.
9. Sehgal PB. (1998). Cytokines in the host-tumor interaction. In: Mackiewicz A, Sehgal PB (eds). Molecular Aspects of Cancer and Its Therapy. Birkhauser Verlag: Basel, pp 89-106.
10. Sehgal PB, Tamm I. (1991). Interleukin-6 enhances motility of breast carcinoma cells. In: Goldberg ID (ed). Cell Motility Factors. Birkhauser Verlag: Basel-Boston-Berlin, pp 178-193.
11. Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N et al. (2009). Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28: 2940-2947.
12. Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB. (1989). Interleukin-6 immunoreactivity in human tumors. Am J Pathol 135: 427-433.
13. Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB. (1989). Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 170: 1649-1669.
14. Tamm I, Cardinale I, Murphy JS. (1991a). Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc Natl Acad Sci USA 88: 4414-4418.
15. Tamm I, Cardinale I, Sehgal PB. (1991b). Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells. Cytokine 3: 212-223.
16. Tamm I, Cardinale I, Kikuchi T, Krueger JG. (1994a). E-cadherin distribution in interleukin-6-induced cell-cell separation of ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 4338-4342.
17. Tamm I, Kikuchi T, Cardinale I, Krueger JG. (1994b). Cell-adhesion- disrupting action of interleukin 6 in human ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 3329-3333. (Pubitemid 24130230)
18. Tamm I, Kikuchi T, Cardinale I, Murphy JS, Krueger JG. (1998). Cytokines in breast cancer cell dyshesion. In: Mackiewicz A, Sehgal PB (eds). Molecular Aspects of Cancer and Its Therapy. Birkhauser Verlag: Basel, pp 89-106.
19. Walter M, Liang S, Ghosh S, Hornsby PJ, Li R. (2009). Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28: 2745-2755.